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a b s t r a c t
Protein carbonylation is a well-documented and quantiﬁable consequence of oxidative stress in several
neuropathologies, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease. Although
oxidative stress is a hallmark of traumatic brain injury (TBI), little work has explored the speciﬁc neural
regions and cell types in which protein carbonylation occurs. Furthermore, the effect of gender on
protein carbonylation after TBI has not been studied. The present investigation was designed to
determine the regional and cell speciﬁcity of TBI-induced protein carbonylation and how this response
to injury is affected by gender. Immunohistochemistry was used to visualize protein carbonylation in the
brains of adult male and female Sprague–Dawley rats subjected to controlled cortical impact (CCI) as an
injury model of TBI. Cell-speciﬁc markers were used to colocalize the presence of carbonylated proteins
in speciﬁc cell types, including astrocytes, neurons, microglia, and oligodendrocytes. Results also
indicated that the injury lesion site, ventral portion of the dorsal third ventricle, and ventricular lining
above the median eminence showed dramatic increases in protein carbonylation after injury. Speciﬁ-
cally, astrocytes and limited regions of ependymal cells adjacent to the dorsal third ventricle and the
median eminence were most susceptible to postinjury protein carbonylation. However, these patterns of
differential susceptibility to protein carbonylation were gender dependent, with males showing
signiﬁcantly greater protein carbonylation at sites distant from the lesion. Proteomic analyses were also
conducted and determined that the proteins most affected by carbonylation in response to TBI include
glial ﬁbrillary acidic protein, dihydropyrimidase-related protein 2, fructose-bisphosphate aldolase C, and
fructose-bisphosphate aldolase A. Many other proteins, however, were not carbonylated by CCI. These
ﬁndings indicate that there is both regional and protein speciﬁcity in protein carbonylation after TBI. The
marked increase in carbonylation seen in ependymal layers distant from the lesion suggests a
mechanism involving the transmission of a cerebral spinal ﬂuid-borne factor to these sites. Furthermore,
this process is affected by gender, suggesting that hormonal mechanisms may serve a protective role
against oxidative stress.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Traumatic brain injury (TBI) is a major public health issue
affecting over 1.7 million Americans annually, with falls, collision
incidents, and motor vehicle accidents being the leading causes of
injury [1]. The consequences of TBI can be complex and long
lasting, resulting in serious disorders that involve progressive
cognitive deﬁcits, epilepsy, and profound behavioral alterations.
Although the molecular and cellular disturbances involved in
these longer-term responses are not well understood, one com-
mon element in the pathology seems to be the establishment of a
chronic inﬂammatory state that can persist in brain for weeks,
months, and perhaps even years after TBI [2,3].
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A hallmark of inﬂammation is oxidative stress, which can be
caused by metabolic dysfunction with numerous potential causes
[4,5]. At the tissue and cellular levels, the pro-oxidative forces of
inﬂammation following an injury can outweigh the capacity of
antioxidative, protective mechanisms such as superoxide dismu-
tase and glutathione peroxidase. The resulting state drives the
formation of reactive oxygen species (ROS) and reactive carbonyl
species (RCS), products of lipid peroxidation by ROS. In TBI, this
condition results from injury-induced ischemia/reperfusion,
hypoxia, elevated intracranial pressure, glutamate excitotoxicity,
and intracellular calcium overload [6,7], all of which contribute to
the breakdown of mitochondrial bioenergetics due, in part, to
abnormally aggregated proteins [3].
An important modiﬁcation of oxidative stress is protein carbo-
nylation, which involves the introduction of carbonyl groups into
protein-bound amino acids. Protein carbonylation may occur
either through direct oxidation of amino acid targets by ROS or
via interaction with RCS, which are themselves the product of lipid
peroxidation [8]. By either mechanism, the resulting carbonyl
modiﬁcations can disrupt protein function and thereby contribute
to injury pathology [9]. Carbonylation has long been utilized as a
metric of oxidative stress levels in various neurodegenerative
pathologies, including multiple sclerosis [10] and Alzheimer's
disease [11]. Although several studies in TBI have explored protein
carbonylation, this work has been largely limited to the use of this
modiﬁcation as a measure of total oxidative stress [12]. Here, we
identify four proteins that are preferentially carbonylated in response
to TBI, investigate the susceptibility of various brain regions to
carbonylation, identify cell types within these regions that are most
affected by this modiﬁcation, and, furthermore, differentiate gender-
based differences in carbonylation after TBI. The results of this work
shed light onto into the differential susceptibility of speciﬁc brain
regions and cell types to TBI-induced oxidative stress, providing
insights into the mechanisms of TBI pathology.
Materials and methods
Controlled cortical impact (CCI)
Adult male and adult female Sprague–Dawley rats (8–9 weeks
of age) were purchased from Charles River Laboratories (Morris-
ville, NC, USA). Rats were housed in a barrier facility for animals
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International. Before experimental proce-
dures, rats were anesthetized with isoﬂurane (Baxter Healthcare
Corp., Deerﬁeld, IL, USA) vaporized in medical-grade oxygen
(100%, Roberts Oxygen Co. Inc., Rockville, MD, USA), placed in a
digital cranial stereotactic device (Leica Microsystems, Buffalo
Grove, IL, USA), and subjected to unilateral CCI injury over the left
hemisphere. Brieﬂy, the rats underwent a free-hand craniotomy
(3.8 mm from bregma in males, 3.0 mm in females). CCI was
administered through the ImpactOne stereotaxic impactor (Leica
Microsystems), which delivered a 3-mm ﬂat-tipped impactor at
201 to a depth of 2 mm at 5 m/s with a 500-ms dwell time. After
CCI, the incision was closed and the rats received buprenorphine
0.05 mg/kg for postoperative analgesia. Throughout all procedures,
rat body core temperature was maintained at 3770.3 1C. Sham-
operated rats received no anesthesia, incision, or craniotomy.
Animals were euthanized 5 days after injury under anesthesia
(10% chloral hydrate solution, 0.4 ml/100 g). All animal handling
procedures were performed in compliance with guidelines from
the National Research Council for the ethical handling of labora-
tory animals and were approved by the Institutional Animal Care
and Use Committee of USUHS (IACUC Protocol APG 12-827,
Bethesda, MD, USA).
Immunoblotting: protein carbonylation detection and identiﬁcation
in brain tissue
Tissue collection and preparation
Brains were removed immediately after euthanization, frozen
on powdered dry ice, and stored at 80 1C until used. Brains were
hand-dissected to produce blocks of penumbral structures
enriched in carbonylated proteins as identiﬁed immunohisto-
chemically (see below). The contralateral brain region and equiva-
lent region from the naïve animals were similarly collected.
One-dimensional gel electrophoresis
Protein fractions were prepared by homogenization in 5 vol-
umes/tissue weight extraction solution (8 M urea, 2% 3-[(3-chola-
midopropyl)dimethylammonio]-1-propane sulfonate (Chaps), and
50 mM dithiothreitol (DTT; Sigma–Aldrich, St. Louis, MO, USA)
containing 0.8% ampholytes (pH 3–10; Invitrogen Life Technolo-
gies, Carlsbad, CA, USA) and 1 Complete protease inhibitor mix
(Roche, Indianapolis, IN, USA)). After homogenization and subse-
quent centrifugation (20,000g, 10 min, 4 1C), the resulting super-
natant was stored at 80 1C until used. The efﬁciency of tissue
solubilization was 495%, as judged by protein assay and Coomas-
sie staining of one-dimensional gels.
Protein samples were prepared for gel electrophoresis by
combining with an equal volume of 2 reducing loading buffer
(Novex NuPAGE LDS sample buffer; Invitrogen; containing 50 mM
DTT) and heating at 70 1C for 10 min. Samples were then fractio-
nated (25 μl/4.16 μg per lane) using NuPAGE 10% Bis–Tris gels
(Novex–Invitrogen) and transferred to nitrocellulose blots using an
iBlot transfer apparatus (Invitrogen).
Fluid-phase isoelectric focusing (IEF)
To reduce the complexity of tissue homogenates for subsequent
proteomic analyses, samples were prefractionated by ﬂuid-phase
IEF before one-dimensional gel electrophoresis. Samples of injured
and contralateral hemisphere, and the corresponding regions from
control naïve animals (n¼8 for each region), were homogenized in
5 volumes (wt/vol) IEF denaturant consisting of 7.7 M urea, 2.2 M
thiourea, and 4.4% Chaps containing 1 Complete protease inhi-
bitor mix (Roche) and clariﬁed by centrifugation (20,000g, 10 min,
4 1C). Tissue region pools were prepared and 200-μl aliquots of
each pool supernatant were further diluted to 2.865 ml having a
ﬁnal composition of IEF denaturant plus ampholytes (150 μl, pH
3–10; Invitrogen), DTT (50 μl, 2 M stock), and bromophenol blue
(10 μl, 10 mg/ml stock). The resulting sample was loaded into the
IEF fractionator and focused using the following conditions: 100 V,
1.2 mA, 0 W (15 min); 200 V, 2.0 mA, 0 W (1 h); 400 V, 2.0 mA,
1 W (1 h); 600 V, 1.5 mA, 1 W (1 h). This resulted in fractions of
proteins within the following pI ranges: 3.0–4.6, 4.6–5.4, 5.4–6.2,
6.2–7, and 7–9.1. IEF-fractionated proteins were further fractio-
nated by size by one-dimensional gel electrophoresis (see One-
dimensional gel electrophoresis).
Postelectrophoretic detection of carbonylated proteins
Postelectrophoretic detection of carbonylated proteins was
performed as described by Conrad et al. [13], with minor mod-
iﬁcations. Brieﬂy, nitrocellulose membranes were washed in 20%
methanol/80% Tris-buffered saline/Tween 20 (TBS-T), equilibrated
in 2 N hydrochloric acid (HCl), and then incubated with 0.5 mM
2,4-dinitrophenylhydrazine (DNPH; Sigma–Aldrich) in 2 N HCl
(10 min, in the dark). The derivatized membranes were then
washed three times with 2 N HCl (10 min per wash) followed by
50% methanol (ﬁve times, 10 min per wash). Membranes were
then equilibrated in TBS-T, blocked with 5% fetal bovine ser-
um/TBS-T, and probed overnight at 4 1C with rabbit anti-DNP
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(Sigma–Aldrich; Catalog No. 9659, 1:1000 in TBS-T). Membranes
were washed three times with TBS-T and probed with horseradish
peroxidase-labeled, goat anti-rabbit IgG (Thermo Fisher Scientiﬁc,
Waltham, MA, USA; Catalog No. 31460, 1:5000 in TBS-T, 3 h). Blots
were washed (TBS-T) and visualized by enhanced chemilumines-
cence (Novex ECL HRP Chemiluminescent Substrate Reagent Kit;
Invitrogen) using a FUJI LAS 3000 imager (Fujiﬁlm, Minato, Tokyo,
Japan). The images were analyzed using MultiGauge version
3.0 software (Fujiﬁlm) and the intensity of protein bands was
quantiﬁed with ImageJ software (W.S. Rasband, ImageJ, U.S.
National Institutes of Health, Bethesda, MD, USA). Immunoreactive
signals were mapped to corresponding protein features of
Coomassie-stained gels. These features were excised and pro-
cessed for identiﬁcation via peptide mass ﬁngerprinting.
Protein identiﬁcation by peptide mass ﬁngerprinting
Coomassie-stained gel pieces were destained in 100 mM
NH4CO3/50% acetonitrile at 37 1C for 90 min. Slices were dehy-
drated in 100% acetonitrile (5 min, at room temperature), followed
by drying under vacuum. The dehydrated gel pieces were rehy-
drated in a minimal volume of a solution of 40 mM NH4CO3/50%
acetonitrile containing 20 ng/μl trypsin (Trypsin Gold, Mass Spec
Grade; Promega, Madison, WI, USA) and incubated overnight at
37 1C. Peptide fragments were recovered from the gel slices by
sequential washes with 75 μl 1% triﬂuoroacetic acid (TFA) (1 h)
and 50 μl 5% TFA/50% acetonitrile (two washes, 1 h per wash). The
washes were pooled, dried under vacuum, and then dissolved in 10 μl
of 1% TFA. Tryptic digests were mixed 1:1 with α-cyanohydroxyc-
innamic acid matrix (10 mg/ml in 50% acetonitrile/0.1% TFA) contain-
ing bradykinin (1060.5692 Da) and adrenocorticotropic hormone
fragment 18–29 (2465.1989 Da) (AnaSpec, San Jose, CA, USA) as
internal standards and analyzed by matrix-assisted laser desorption
ionization time-of-ﬂight (MALDI-TOF) mass spectrometry, using a
Voyager MALDI-TOF DE STR instrument (PE Biosystems). Peptide mass
spectra data were analyzed via the Protein Prospector MS-Fit search
engine (http://prospector.ucsf.edu/). Criteria for a positive identiﬁca-
tion were a MOWSE score greater than 1.00107 and more than two
times greater than any other identiﬁcations for the search, a coverage
percentage greater than 25%, and a matched protein identifying with
the appropriate molecular weight and pI for the fractionation
procedure.
Immunohistochemistry
Tissue collection and preparation
Euthanized animals were perfused transcardially with 200 ml
phosphate-buffered saline (PBS) followed by 200 ml 4% parafor-
maldehyde for ﬁxation. Brains were stored in 4% paraformalde-
hyde overnight at 4 1C and then equilibrated in a 30% sucrose
solution (48 h, 4 1C). Coronal sections (20 μm thick) were
collected from 2.5 mm rostral to 2.5 mm caudal to the CCI lesion
site and mounted onto Colormark Plus adhesion slides (Thermo
Fisher Scientiﬁc). Every tenth section was stained with thionine to
create a reference library.
Detection of carbonylated proteins and cell-speciﬁc markers
Immunostaining for protein carbonyls was performed as described
by Zheng and Bizzozero [8], with minor modiﬁcations. Each section
was prepared by incubation with 100 μl DNPH (1 mg/ml in 2 N HCl)
for 30 min at room temperature. Sections were then washed three
times with 0.2% Triton X-100/PBS and blocked for 1 h at room
temperature with 10% normal donkey serum. After three more washes
with 0.2% Triton X-100/PBS, each tissue section was incubated at 4 1C
overnight with 100 μl of 1:1000 rabbit anti-DNP (Sigma–Aldrich;
Catalog No. D9656) in 0.3% Triton X-100/PBS. Colocalization
experiments were performed by co-incubating sections with cell-
speciﬁc markers: mouse anti-NeuN (detects neurons; EMD Millipore,
Billerica, MA, USA; Catalog No. MAB377; 1:1000), mouse anti-glial
ﬁbrillary acidic protein (GFAP; detects astrocytes; EMD Millipore;
Catalog No. MAB360; 1:1000), goat anti-Iba1 (detects microglia and
macrophages; Abcam, Cambridge, UK; Catalog No. ab5076; 1:100), and
mouse anti-Olig2 (detects oligodendrocytes; EMD Millipore; Catalog
No. MABN50, 1:100). Slides were washed three times with 0.2% Triton
X-100/PBS and then incubated with 100 μl secondary antibody solu-
tion: 1:100 donkey anti-rabbit IgG (HþL), conjugated to green-
ﬂuorescent Alexa Fluor 488 dye (Invitrogen); 1:100 donkey anti-
mouse or anti-goat IgG (HþL), conjugated to red-ﬂuorescent Alexa
Fluor 594 dye (Invitrogen; Catalog Nos. A-21203 and A-11058,
respectively). After 3 h of incubation, this solution was replaced with
40,6-diamidino-2-phenylindole (DAPI; Sigma–Aldrich; Catalog No.
D32670, 0.01% in 0.2% Triton X-100/PBS, 5 min at room temperature)
for nuclear staining. Sections were washed three times with 0.2%
Triton X-100/PBS and one time with 1 PBS and then visualized with
a Zeiss LSM 5 Pascal confocal microscope (Zeiss, Jena, Germany).
Preadsorption control
Speciﬁcity of the carbonylation immunohistochemistry was
conﬁrmed by immunoneutralizing the primary antibody with
carbonylated protein standard. Brieﬂy, β-casein protein was che-
mically carbonylated by incubation with ferric chloride (FeCl3)
(15 mg in 2 ml 37.5 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (Hepes), pH 7.2, containing 37.5 mM ascorbate and
0.15 mM FeCl3; 5 h, 37 1C). The reaction mixture was then dialyzed
against 50 mM Hepes and 1 mM ethylenediaminetetraacetic acid
(pH 7.2) overnight at room temperature. A control reaction was
conducted similarly with the absence of FeCl3. Derivatization of
protein carbonyl groups was carried out by combining the protein
dialysates with an equal volume of 12% sodium dodecyl sulfate
and an equal volume of 10 mM DNPH prepared in 1 N HCl.
Reactions proceeded in the dark for 15 min at room temperature
and were then neutralized with the addition of 3.25 ml 2 M Tris–
HCl. The derivatized proteins were dialyzed against H2O overnight.
The carbonylation status of the two preparations was conﬁrmed
by Western blot using anti-DNP immunodetection. Preadsorption
of the primary antibody was carried out by incubating anti-DNP
IgG (2 μg) with carbonylated, DNPH-derivatized β-casein
(100 μg protein) at 4 1C, overnight. An additional control condi-
tion was established by similarly incubating anti-DNP antibody in
the absence of modiﬁed β-casein protein.
Statistical analysis
Carbonylation immunohistochemistry was quantiﬁed accord-
ing to region using a blinded scoring system, with 0 reﬂecting the
lowest amount of carbonylation ﬂuorescence intensity in a region
and 3 reﬂecting the greatest amount across all sections evaluated.
Regions scored were the cortical lesion site, dorsal third ventricle,
and median eminence. Sixteen brain sections per animal were
scored using sections located from bregma 2.12 mm to bregma
3.30 mm (control/CCI male rats n¼7 and 9, respectively;
control/CCI female rats n¼9 and 7, respectively). Comparisons
between groups were analyzed by ANOVA with a Tukey HSD post
hoc test. po0.05 was considered signiﬁcant (MultiGauge version
3.0 software; Fujiﬁlm).
Results
CCI increases protein carbonylation in speciﬁc regions of the brain
An initial immunoblotting experiment was performed to con-
ﬁrm that the CCI model resulted in a reproducible pattern of
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protein carbonylation in brain. We investigated the proﬁle of
carbonylated proteins in whole-brain lysates. Injured brain lysates
were compared to contralateral uninjured tissue lysates from the
same animal using Coomassie staining and Western blotting for
DNP in one-dimensional gels (Fig. 1). Total carbonylation (based on
total lane intensity) was increased approximately 10% in samples
from injured brain tissue compared to the signal observed in
contralateral, uninjured brain tissue. Interestingly, carbonylation
was enhanced for a small group of speciﬁc protein features
(arrows) in response to CCI. These results conﬁrmed that CCI
causes the upregulation of carbonylation of speciﬁc proteins.
Peptide mass ﬁngerprinting was used to identify speciﬁc
proteins carbonylated in response to CCI. Fig. 2 presents a
representative analysis in which proteins present in control and
TBI extracts were fractionated by ﬂuid-phase IEF, followed by one-
dimensional gel electrophoresis. Proteins having enhanced carbo-
nylation after injury were visualized by Western blotting for DNP,
mapped to corresponding features on Coomassie-stained gels, and
identiﬁed as GFAP, dihydropyrimidase-related protein 2 (also known
as collapsing response mediator protein 2, or CRMP2), fructose-
bisphosphate aldolase C (ALDOC), and fructose-bisphosphate aldolase
A (ALDOA).
To identify speciﬁc regions of the brain in which increased
protein carbonylation occurred after TBI, we performed anti-DNP
immunohistochemistry. Total brain DNP staining is displayed in
Fig. 3, with the site of CCI indicated in the upper left cortex.
At higher magniﬁcation, the ﬂuorescence intensity of anti-DNP
labeling in the vicinity of the lesion was clearly distinguished from
that observed in the uninjured contralateral cortex (Figs. 4A and B,
respectively). The speciﬁcity of the immunolabeling was conﬁrmed by
immunoneutralization of the anti-DNP primary antibody. Preincuba-
tion of the antibody with a carbonylated control protein, β-casein,
effectively eliminated anti-DNP labeling in injured brain tissue
(Fig. 4C). No reduction in signal was observed using anti-DNP antibody
preincubated with unmodiﬁed β-casein (Fig. 4D).
In addition to the immediate area of the lesion, CCI increased
protein carbonylation in the region of the dorsal third ventricle
(Figs. 5A and B) and the median eminence (Figs. 5C and D)
Fig. 1. Effects of CCI on protein carbonylation in rat brain. Five days after experimentally administered CCI, extracts were obtained from dissected regions of brain containing
the injury penumbra (I) and the corresponding contralateral control region (C). Lysates were analyzed (4.2 μg/lane) for protein carbonylation by one-dimensional gel
electrophoresis followed by Western blotting. Coomassie staining of the protein remaining in the transferred gel was used to conﬁrm equal protein loading (left). DNP
Western blotting was performed to detect protein carbonylation in CCI-injured brain samples versus uninjured contralateral brain samples (right). Arrows indicate protein
bands for which carbonylation was most affected by CCI. Images are representative of three independent experiments. A total of n¼5 CCI animals were examined.
Fig. 2. Identiﬁcation of rat brain proteins carbonylated after CCI. Proteins present in extracts of naïve rat brain (N) and contralateral (C) and ipsilateral (I) regions of CCI-
injured rats were fractionated by ﬂuid-phase IEF (pI ranges listed at bottom) and one-dimensional gel electrophoresis. Proteins were transferred to nitrocellulose,
derivatized, and probed with anti-DNP antibody (right). Proteins remaining in the gel were visualized by Coomassie staining (left). Features showing increased carbonylation
in response to TBI (numbered boxes, right) were mapped to the corresponding Coomassie features (left) and identiﬁed by peptide mass ﬁngerprinting as: (1) GFAP
(49,957 Da; pI 5.4), (2) CRMP2 (62,278 Da; pI 6.0), (3) ALDOC (39,284 Da; pI 6.7), and (4) ALDOA (39,352 Da; pI 8.3). Images are representative of three independent
experiments. A total of n¼8 CCI and n¼8 naïve animals were examined.
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compared to these regions in sham, control animals. Staining was
especially pronounced in the ependymal cells lining the third
ventricle of both regions. In comparison, basal levels of anti-DNP
immunoﬂuorescence in the equivalent regions of sham control ani-
mals were very low. The most intense anti-DNP immunoﬂuorescence
after CCI was also observed in ependymal cells located adjacent to
the paraventricular thalamic nuclei in the CCI-injured animals
(Fig. 5B). Fig. 5 also shows anti-DNP immunoﬂuorescence in the
median eminence region of control and CCI-lesioned rats (Figs. 5C
and D, respectively). Immunolabeling was concentrated in the
ependymal cells and processes lining the ﬂoor of the third
ventricle at the median eminence of CCI animals (Fig. 5D). This
pattern of intense labeling was not observed in comparable
sections prepared from uninjured control animals (Fig. 5C).
Together, these immunohistochemical ﬁndings indicate that dis-
crete regions of the brain exhibit an upregulation of protein
carbonylation after CCI. This response is most pronounced in the
cortical area surrounding the area of injury and in the ependymal
areas of the dorsal third ventricle/paraventricular region and the
median eminence.
Cell speciﬁcity of CCI-induced protein carbonylation
Experiments involving dual immunohistochemical staining
were conducted to identify the cell types exhibiting increased
protein carbonylation after CCI. The increase in carbonylation
observed in the brain tissue surrounding the lesion was most
signiﬁcantly associated with astrocytes (Figs. 6A–C). Anti-DNP
Fig. 3. Effects of CCI on protein carbonylation immunohistochemistry in rat brain. Brain
tissue was collected 5 days after CCI and evaluated by anti-DNP immunoﬂuorescence. A
whole-slice image (top, 1 original magniﬁcation, scale bar indicates 2 mm) and an
image of the lesion site (bottom, 2.5 original magniﬁcation, scale bar indicates 2 mm)
are shown. Images are representative of three independent experiments. A total of
n¼16 CCI animals and n¼16 sham animals were examined, with 16 slices per animal
from bregma 2.12 mm to bregma 3.30 mm.
Fig. 4. The CCI-induced increase in anti-DNP immunoﬂuorescence is speciﬁc for protein carbonylation. Brain tissue was collected 5 days after CCI and evaluated by anti-DNP
immunoﬂuorescence. Anti-DNP immunoﬂuorescence in the cerebral cortex contralateral to the injury and the CCI-injured cortex are depicted in (A) and (B), respectively
(original magniﬁcation 10, scale indicates 200 μm). Immunoneutralization of the anti-DNP antibody with (C) carbonylated and derivatized β-casein but not (D) unmodiﬁed
β-casein resulted in reduced DNP immunohistochemical staining of the CCI-injured brain (original magniﬁcation 20, scale bar, 100 μm). Images are representative of three
independent experiments. A total of n¼16 CCI animals and n¼16 sham animals were examined, with 16 slices per animal from bregma 2.12 mm to bregma 3.30 mm.
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labeling predominantly colocalized with that of anti-GFAP, a
marker for astrocytes. Labeling by anti-DNP was observed within
both astrocytes (Figs. 6A–C, white arrows) and enlarged, GFAP-
negative cells undergoing apparent degeneration (Figs. 6A–C, red
arrows). In some cases, astrocytic foot processes appeared to surround
these enlarged cells. The vast majority (490%) of astrocytes in the
injury lesion expressing carbonylated proteins were reactive astro-
cytes, as judged by enhanced GFAP expression, cellular hypertrophy,
and disruption of individual cellular domains [23].
Immunohistochemical labeling of carbonylated proteins in the
penumbra region also appeared in neurons, as indicated by the
colocalization of anti-DNP and anti-NeuN labeling (Figs. 6D–F,
white arrows). However, this colabeling was limited to only a
relatively small proportion of the total number of neurons visua-
lized by NeuN, compared to the relatively greater amount of
carbonylated proteins within astrocytes as visualized by GFAP.
Data also indicated that protein carbonylation was not signiﬁcantly
associated with oligodendrocytes, microglia, or macrophages.
Gender inﬂuences regional patterns of protein carbonylation
A number of studies have indicated that gender plays a role in
determining the consequences of oxidative injuries of the brain
[14,15]. The present investigation sought to determine whether
gender affects protein carbonylation after CCI. A scoring system
was developed to quantitatively assess the effects of CCI on protein
carbonylation and to investigate the inﬂuence of gender on the
response. The scoring system was based on overall intensity and
extent of anti-DNP immunoﬂuorescence detected in each region.
Scores were developed on a 0–3 scale for each region examined. A
score of 0 reﬂected the basal state of carbonylation observed in control
animals and a score of 3 was assigned to the greatest signal observed
for a given region, across all animals studied. Representative images
for scoring of each region of interest are presented in Fig. 7.
As shown in Figs. 8 and 9, immunohistochemical and quanti-
tative analysis indicated that the degree of protein carbonylation
observed in the area of acute injury, 5 days after CCI, did not
appreciably differ between male and female rats in that both
genders had a maximal score of 3.
The response in the injury area was sixfold greater than that
observed in regions of cerebral cortex distant from the lesion site
(nnnpo0.0001). The carbonylation score for the contralateral
cortex of injured animals was not different from the score
observed in the sham animal group. There were no gender
differences observed across cortical regions compared here.
We next analyzed the effects of gender on CCI-induced protein
carbonylation in the dorsal third ventricle and median eminence
regions of brain. As shown in Fig. 10, carbonylation scores for
median eminence of control animals were higher for males
compared to females. This gender difference was further reﬂected
in the response to CCI in that carbonylation scores were signiﬁ-
cantly elevated over control values in males but only tended to be
Fig. 5. Effects of CCI on protein carbonylation in ependymal cells lining the dorsal third ventricle and median eminence. Brain tissue was collected 5 days after CCI and
evaluated by anti-DNP immunoﬂuorescence (A and C, sham control; B and D, CCI). (A and B) Representatives of the dorsal third ventricle. (C and D) Representatives of the
ventricle lining above the median eminence. After CCI, ependymal cells lining the dorsal third ventricle became highly immunoreactive, as did distinct cells located in the
adjacent parenchyma of the paraventricular thalamic nucleus (B, arrows). Also after CCI, cells lining the ventricle of the median eminence showed an increase in protein
carbonylation (D). (A and B) Original magniﬁcation 20, scale 50 μm. (C and D) Original magniﬁcation 40, scale 50 μm. Images are representative of three independent
experiments. A total of n¼16 CCI animals and n¼16 sham animals were examined, with 16 slices per animal from bregma 2.12 mm to bregma 3.30 mm.
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so in females. A similar pattern was observed in the dorsal third
ventricle, in which CCI-induced protein carbonylation was signiﬁ-
cantly greater in males compared to females. The carbonylation
state of the dorsal third ventricle of control males tended to be
higher than that of control females; however, this difference did
not achieve statistical signiﬁcance.
Discussion
Protein carbonylation is a well-documented consequence and
measureable indicator of oxidative stress in multiple neuropathol-
ogies, including Alzheimer's disease and Parkinson's disease [16].
Recently, interest has focused on the role of oxidative stress in the
pathology of TBI [17]. To date, research has concentrated on
measures of global carbonylation within the central nervous
system, whereas little work has explored the neural regions, cell
types, and speciﬁc proteins affected by this modiﬁcation. Further-
more, although signiﬁcant research has identiﬁed gender-based
differences in TBI prognosis [14,18], few researchers have exam-
ined how gender affects the magnitude or regional distribution of
protein carbonylation after TBI.
The pathophysiology of TBI is both complex and dynamic,
involving physical injury, ischemia/reperfusion, hypoxia, glutamate
excitotoxicity, intracellular calcium overload, and elevated intracra-
nial pressure [6,7,19,20]. Collectively, these conditions establish an
environment of mitochondrial dysfunction, marked by the gen-
eration of ROS, including superoxide and hydrogen peroxide.
These molecules drive the formation of RCS, such as acrolein and
4-hydroxynonenal, which are by-products of lipid peroxidation
[21,22]. RCS, in turn, catalyze the generation of intraprotein
carbonyls, further compromising cellular functions and exacerbat-
ing injury pathology. The data from this investigation show that
the astrocytes in the immediate area of the injury lesion site, along
with the ependymal cells lining the dorsal third ventricle and the
ﬂoor of the third ventricle above the median eminence, contain
the highest levels of protein carbonylation at 5 days after CCI. A
time point of 5 days postinjury was considered to be sufﬁciently
removed from the injury event to gain insights into the longer-
term processes involved in brain injury. Whereas both genders
showed similar levels of protein carbonylation at the site of injury,
males showed a greater increase in carbonylation in ependymal
cells distant from the lesion.
Within the injury region, the vast majority of astrocytes rich in
carbonylated proteins were reactive astroglia, as indicated by
complex, overlapping processes and hypertrophic cell bodies
[23]. Astrocytes have been proposed to be the ﬁrst line of defense
against oxidative stress after acute TBI [24–26]. Astrocytes play
Fig. 6. CCI-induced protein carbonylation is most signiﬁcantly associated with astrocytes in the region of a CCI lesion. Brain tissue was collected 5 days after CCI and
evaluated by coimmunoﬂuorescence. (A–C) Representatives of the astrocyte and DNP detection at the injury site, (D–F) representatives of neuron and DNP detection at the
injury site. Carbonylated proteins within the penumbra region were identiﬁed by anti-DNP immunohistochemistry (green, A and D). (B) and (E) represent anti-GFAP
(astrocytes, red) and anti-NeuN (neurons, red) detection, respectively, in the injury lesion. (B) also illustrates counterstaining with DAPI (blue) for the detection of nuclei.
Merged images (C and F) indicate the detection of carbonylated proteins and their relation to astrocytes (C) and neurons (F). Astrocytes containing carbonylated proteins are
shown in yellow (C). Astrocyte bodies and processes (red) contained carbonylated proteins (green, A), resulting in a yellow colocalization signal as indicated by white arrows
(C). Astrocyte processes surrounding degenerating cells that contained carbonylated proteins are indicated by pink arrows (C). Neurons were identiﬁed using anti-NeuN (red,
E), and protein carbonylation was identiﬁed using anti-DNP (green, D) The merged image indicates locations where both labels occur (yellow, F). Arrows indicate neurons
that contained carbonylated proteins. (A–C) Original magniﬁcation 40, scale 50 μm. (D–F) Original magniﬁcation 20, scale 100 μm. Images are representative of three
independent experiments. A total of n¼3 CCI animals and n¼3 sham animals were examined, with four slices per animal from bregma 2.12 mm to bregma 3.30 mm.
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Fig. 7. Representative images depicting the carbonylation scoring system. Brain tissue was collected 5 days after CCI and evaluated by anti-DNP immunoﬂuorescence. Images
show relative increments in anti-DNP immunoﬂuorescence (0–3) observed in the penumbra/cortex, dorsal third ventricle, and median eminence regions. The distinguishing
feature differentiating a score of 2 versus a score of 3 for the dorsal third ventricle was the anti-DNP labeling of peri-ependymal cells located in the parenchyma both lateral
and ventral to the dorsal third ventricle. This observation reﬂected a stippled pattern of carbonylation-positive cells expanding approximately 10 to 50 μm into surrounding
tissue from the ependymal lining of the ventricle. Penumbra/cortex and median eminence images, original magniﬁcation 10; dorsal third ventricle images, original
magniﬁcation 20. Images are representative of three independent experiments. A total of n¼16 CCI animals and n¼16 sham animals were examined, with
16 slices per animal from bregma 2.12 mm to bregma 3.30 mm.
Fig. 8. Gender did not affect the degree of protein carbonylation in the cerebral cortex of control and CCI-lesioned rats. Brain tissue was collected 5 days after CCI and
evaluated by anti-DNP immunoﬂuorescence. As shown qualitatively for a representative (A) male and (B) female, and quantitatively in Fig. 10, the degree of protein
carbonylation after CCI in the penumbra region was not signiﬁcantly affected by gender. Original magniﬁcation 20, scale 100 μm. Images are representative of three
independent experiments. A total of n¼16 CCI animals (7 female, 9 male) were examined, with 16 slices per animal from bregma 2.12 mm to bregma 3.30 mm.
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a key role in balancing the oxidative load of the brain after injury,
through their ability to scavenge ROS and thereby buffer the
spread of oxidative stress [27]. Whereas astrocytes have the
capacity to combat oxidative stress to the beneﬁt of other adjacent
cells, they themselves are still vulnerable to the actions of ROS,
which can cause mitochondrial damage, accelerated senescence,
and cell death [28,29]. Our results support these conclusions by
demonstrating that at the site of lesion, astrocytes are the
dominant cell type showing increased protein carbonylation
post-CCI. Whereas some neurons exhibited increased protein
carbonylation after CCI, this response was minimal in comparison
to astrocytes. The carbonylation status of oligodendrocytes and
microglia and macrophages in the lesion area was essentially
unaffected by CCI.
Our data indicate that CCI induces carbonylation in a subpo-
pulation of cells distant from the region of the acute injury,
speciﬁcally, in the ependymal lining of the dorsal third ventricle
and median eminence. This unanticipated response was more
pronounced in male rats compared to females. Ependymal cells
form a barrier between cerebrospinal ﬂuid (CSF) and neural tissue,
acting as both a physical and a metabolic interface [30]. The
mechanism by which oxidative damage is transmitted to speciﬁc
regions of the ependymal system is not fully understood, but may
involve: (1) the transport of reactive molecules from the site of
injury via the CSF and (2) a selective sensitivity of the ependymal
lining of the dorsal third ventricle and median eminence to these
mediators. Likely CSF-borne molecules include 4-hydroxynonenal,
acrolein, and malondialdehyde, all of which are highly reactive
aldehyde products of ROS-catalyzed lipid peroxidation. Unlike
ROS, however, these compounds are relatively long-lived and can
withstand extracellular transport from their site of generation
[22,31]. In this regard, elevated levels of 4-hydroxynonenal have
been documented in the CSF of patients with neuropathologies,
including amyotrophic lateral sclerosis [32] and Parkinson's dis-
ease [33]. The selective sensitivity of speciﬁc ependymal zones
lining the dorsal third ventricle and area above the median
eminence may reﬂect unique functional characteristics of the cells
involved. In support of this proposal, ependymal cells lining the
ventricles of the brain have been shown to display a broad range of
heterogeneity with respect to structure and function [34,35],
membrane protein expression [35], and vulnerability to CSF-
borne toxins [34]. Similarly, the ependymal lining at the base of
the third ventricle, directly above the median eminence, is well
known for its unique structure [36], neurogenic cell populations
[37], and neuroendocrine regulation [38]. Therefore, we propose
that aldehyde by-products of lipid peroxidation are generated by
ROS at the site of acute injury, are transported through the
cerebroventricular system, and interact with susceptible, CSF-
adjacent periventricular ependymal cells to propagate carbony-
lated protein species.
The signiﬁcance of increased protein carbonylation in the
ependymal regions is not yet fully understood. It is known that a
subset of ependymal cells of both the median eminence and the
dorsal third ventricle extend foot-like processes into the brain
parenchyma and onto resident capillaries [39]. Moreover, this subset
exhibits endocytosis of macromolecules from the CSF [36], which
could lead to a local accumulation of RCS, thus propagating protein
carbonylation. Our present immunohistochemical ﬁndings are also
consistent with the proposal that carbonylation-containing ependymal
cells may expand into the surrounding parenchyma, possibly serving
as a mechanism for repair.
This investigation is the ﬁrst to examine the effects of gender
on the differential patterns of protein carbonylation after TBI. Basal
levels of protein carbonylation were low but detectable in all brain
regions investigated here. Interestingly, normal male rats exhib-
ited a signiﬁcantly greater degree of protein carbonylation in the
ependymal zones of the dorsal third ventricle and median emi-
nence compared to normal females. TBI produced dramatic and
comparable increases in carbonylation in the acute injury region in
both male and female rats. However, injured males showed a
signiﬁcantly greater increase in protein carbonylation than injured
females in the ependymal zones of the dorsal third ventricle and
median eminence, sites distant from the lesion. Accordingly,
whereas male and female rats seem to respond similarly at the
site of acute injury, females may be more resistant to secondary
processes at sites distant to the injury. In this regard, clinical
studies document that female patients exhibit reduced mortality
and decreased complications after TBI [14,18,40]. It has been
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Fig. 9. Effects of CCI on protein carbonylation in regions of the cerebral cortex of male and female rats. Brain tissue was collected 5 days after CCI and evaluated by anti-DNP
immunoﬂuorescence. Sections were scored for protein carbonylation as described under Material and methods. Data indicate means 7 SEM. A post hoc Tukey HSD analysis
indicated a statistically signiﬁcant difference (nnnpo0.001) between the scores of the penumbra versus other cortical regions of the injured and sham animals. Graph is
representative of three independent experiments. A total of n¼16 CCI animals (7 female and 9 male) and n¼16 sham animals (9 female and 7 male) were examined, with 16
slices per animal from bregma 2.12 mm to bregma 3.30 mm.
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proposed that the ovarian steroid hormone progesterone serves to
regulate metabolic functions in the brain [41] and counteracts the
excitotoxic effects of TBI [42–44], possibly by protecting against
lipid peroxidation and the generation of RCS [45].
Although it is well recognized that oxidative stress drives many
processes of secondary injury after brain injury, clinical trials
involving antioxidant interventions have had limited success in
preventing the sequelae of TBI [46–50]. Our ﬁndings indicate that
oxidative stress from TBI occurs within 5 days of injury, both
locally at the site of acute impact and at sites distant from the site
of impact. The lack of efﬁcacy from antioxidants may be due to
postinjury delays such that the irreversible effects of protein
carbonylation may have occurred well before antioxidants could
be applied. TBI-induced protein carbonylation and other forms of
oxidative stress occur rapidly and effects appear to persist for
extended periods of time after injury [51–54]. Accordingly, timely
administration of antioxidant therapy postinjury has been difﬁcult
to achieve clinically. Also, multiple mechanisms are involved in the
processes of oxidative stress, suggesting that a single treatment
strategy may be inadequate in targeting the full spectrum of
oxidative processes requiring management.
The research here has identiﬁed the selective carbonylation of
GFAP, CRMP2, ALDOA, and ALDOC in response to TBI. The identi-
ﬁcation of GFAP, a major component of astrocytes, is consistent
with our immunohistochemical ﬁndings, showing that these cells
are particularly susceptible to oxidative modiﬁcation after injury.
GFAP, CRMP2, and ALDOC have all been identiﬁed as being
carbonylated in Alzheimer's disease [11,55], indicating a potential
role for this modiﬁcation in long-term neuropathology. Recent
work by Oikawa and associates [56] examining the effects of
ischemia/reperfusion injury on the carbonylated proteome of the
monkey hippocampus also showed enhanced carbonylation of
CRMP2 and ALDOC. Additionally, GFAP is a major target for
carbonylation in experimental autoimmune encephalitis, a murine
model of multiple sclerosis [8]. All four of the proteins identiﬁed in
this work are also functionally grouped, as they all contribute to
the maintenance of cellular structure [57–60]. In addition, CRMP2
functions in axonal guidance, serving an important role in neuro-
nal regeneration after injury [61]. Taken together, these ﬁndings
suggest that carbonylation may provide a proteomic basis for
mechanisms of sustained pathology after TBI. Understanding the
mechanisms, nature, localization, and timing of protein modiﬁca-
tions after TBI may provide a guide for the development of more
effective TBI therapies that target both oxidative stress and its
downstream consequences.
Conclusion
In conclusion, this study demonstrates in rats that TBI induces
carbonylation in speciﬁc brain regions, cell types, and proteins and
that males are more susceptible to TBI-induced protein carbonyla-
tion than females. These results suggest that: (1) region-speciﬁc
protein carbonylation may play an important role in the etiology of
TBI pathology and (2) females are less susceptible to the ongoing
pathological spread of protein modiﬁcations after injury. These
gender-speciﬁc effects may point to possible approaches for
intervention to address the secondary, pathological spread of
protein modiﬁcations after TBI-induced oxidative stress.
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